Mice pretreated with inhaled CBD for 14 days showed a significant reduction in the expression of immune evasion markers, IDO and PD-L1, in GBM tumors compared to both the placebo and 3-day CBD groups. The gene discussed is IDO1; the disease is glioblastoma.